TY  - CONF

T1  - Oral ibandronate and intravenous zoledronic acid in metastatic breast cancer patients: Comparative bone turnover marker and safety data

JO  - BONE

PY  - 2006/03/01

AU  - Body JJ

AU  - Lichinitser M

AU  - Coleman RE

AU  - Bergstrom B

ED  - 

DO  - DOI: 10.1016/j.bone.2006.01.014

VL  - 38

IS  - 3

SP  - S69

EP  - S69

Y2  - 2025/10/10

ER  -